Castillo Caribe estate redefines luxury in the Cayman Islands
June 02, 2024 21:24 ET
|
Castillo Caribe
Grand Cayman, Cayman Islands, June 02, 2024 (GLOBE NEWSWIRE) -- For those seeking an unparalleled tropical paradise, Castillo Caribe beckons with world-class amenities and breathtaking natural...
罗切斯特大学伊斯曼音乐学院荣登 QS 世界大学排名
June 02, 2024 21:00 ET
|
University of Rochester
纽约州罗切斯特市, June 03, 2024 (GLOBE NEWSWIRE) -- 罗切斯特大学伊斯曼音乐学院在著名的 2024 年 QS 世界大学排名中荣获殊荣。伊斯曼音乐学院在北美排名第 3 位，全球排名第 11 位，与英国、法国、俄罗斯、中国、芬兰、丹麦和匈牙利的顶尖音乐院校同台竞技。 ...
รายงาน GBCI: จีนแผ่นดินใหญ่จัดอยู่ในเขตอำนาจศาล APAC ที่ซับซ้อนที่สุดในการทำธุรกิจ เขตปกครองพิเศษฮ่องกงยังคงเป็นประเทศใน APAC ที่มีความซับซ้อนน้อยที่สุดในการลงทุน
June 02, 2024 21:00 ET
|
TMF Group B.V.
ลอนดอน, June 03, 2024 (GLOBE NEWSWIRE) -- TMF Group ผู้ให้บริการชั้นนำด้านการปฏิบัติตามกฎระเบียบและการบริหาร ได้เปิดตัว Global Business Complexity Index (GBCI) ฉบับที่ 11 ในวันนี้...
GBCI report: Mainland China ranks among the most complex APAC jurisdictions in which to do business. Hong Kong, SAR remains the least complex APAC country to invest in
June 02, 2024 21:00 ET
|
TMF Group B.V.
This report presents the overview of complexity of doing business using 292 annual tracked indicators relating to the APAC jurisdictions.
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
June 02, 2024 20:38 ET
|
Immutep Limited
Phase III collaboration will evaluate efti in combination with KEYTRUDA, MSD’s anti-PD-1 therapy, and standard chemotherapy in first-line non-small cell lung cancer (1L NSCLC)TACTI-004 Phase III trial...
Global HVDC Transmission Market: Comprehensive Overview, Trends and Analysis
June 02, 2024 20:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, June 02, 2024 (GLOBE NEWSWIRE) -- The HVDC Transmission Market is expected to reach USD 14.9 billion by 2028 from USD 11.4 billion in 2023, at a CAGR of 5.4% during the 2023–2028 period. ...
Mesoblast Corporate Presentation at Investor Conference
June 02, 2024 20:23 ET
|
Mesoblast Limited
NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference. Dr....
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
June 02, 2024 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that results from FRUTIGA,...
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2024 19:00 ET
|
Caribou Biosciences, Inc.
-- CB-010 allogeneic CAR-T cell therapy with partial HLA matching has potential to rival efficacy and safety profile of approved autologous CAR-T cell therapies -- -- 14.4 months median PFS in ANTLER...
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
June 02, 2024 18:43 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License...